{
    "root": "657f48b0-40b3-4a06-a244-741044b43d7d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "KYBELLA",
    "value": "20241030",
    "ingredients": [
        {
            "name": "DEOXYCHOLIC ACID",
            "code": "005990WHZZ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28834"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17987"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC",
            "code": "GR686LBA74",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37586"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_26710"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        }
    ],
    "indications": {
        "text": "kybella\u00ae ( deoxycholic acid ) injection indicated improvement appearance moderate severe convexity fullness associated submental fat adults . limitations safe effective kybella treatment subcutaneous fat outside submental region established recommended .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "0.2 ml injections spaced 1 cm apart sites planned treatment area injected . ( 2.1 ) 50 injections 10 ml may injected single treatment . ( 2.1 ) 6 single treatments may administered intervals less 1-month apart . ( 2.1 ) general considerations injection technique injection . ( 2.2 , 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "kybella ( deoxycholic acid ) injection , 10 mg/ml clear , colorless , sterile solution supplied 2 ml , single patient vials following dispensing pack : 4 vials , ndc 61168-101-04 store 20\u00b0c 25\u00b0c ( 68\u00b0f 77\u00b0f ) ; excursions permitted 15\u00b0c 30\u00b0c ( 59\u00b0f 86\u00b0f ) [ usp controlled room temperature ] . kybella unique hologram vial label . hologram , product call 1-800-678-1605. vial single patient . dilute mix kybella compounds . discard unused portion .",
    "adverseReactions": "kybella injection contraindicated presence infection injection sites .",
    "indications_original": "KYBELLA\u00ae (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat\u00a0in adults.\n                  \n                     Limitations of use\n                  \n                  The safe and effective use of KYBELLA\u00a0for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.",
    "contraindications_original": "0.2\u00a0mL\u00a0injections spaced\u00a01\u00a0cm apart\u00a0until all sites in the planned treatment area have been injected.\u00a0( 2.1 ) Up to 50 injections or 10 mL may be injected in a single treatment. ( 2.1 ) Up to 6 single\u00a0treatments may be administered at intervals no less than 1-month apart. ( 2.1 ) See General Considerations for Administration and Injection Technique before injection. ( 2.2 , 2.3 )",
    "warningsAndPrecautions_original": "KYBELLA\u00a0(deoxycholic acid) injection,\u00a010\u00a0mg/mL is a clear, colorless, sterile solution supplied\u00a0in 2\u00a0mL,\u00a0single patient use\u00a0vials\u00a0in the following dispensing pack:\n                  4 vials, NDC\u00a061168-101-04\n                  Store at 20\u00b0C to\u00a025\u00b0C (68\u00b0F to 77\u00b0F); excursions are permitted between\u00a015\u00b0C to\u00a030\u00b0C (59\u00b0F to 86\u00b0F) \u00a0[See USP Controlled Room Temperature].\n                  KYBELLA\u00a0has a unique hologram on the vial label. \u00a0If you do not see a hologram, do not use the product and call 1-800-678-1605. \n                  Each vial is for a single patient use. \u00a0Do not dilute or mix KYBELLA with other compounds. \u00a0Discard unused portion.",
    "adverseReactions_original": "KYBELLA\u00a0injection is contraindicated\u00a0in the presence of infection at the injection sites.",
    "drug": [
        {
            "name": "KYBELLA",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28834"
        }
    ]
}